DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Singleton JW, Hanauer SB, Gitnick GL. et al.
Mesalamine capsules for the treatment of active Crohn’s disease: results of a 16-week trial. Pentasa Crohn’s Disease Study Group.
Gastroenterology 1993; 104: 1293-1301
We do not assume any responsibility for the contents of the web pages of other providers.